PAdd image
Prostamax
Sexual HealthSingleA Khavinson bioregulator marketed for prostate-tissue support in age-related changes.
Half-life
—
Common dose
10 – 20 mg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
Theorized to act as a tissue-specific bioregulator targeting prostate epithelium gene expression.
Protocol notes
Typical protocols: 10–20 mg subcutaneously daily for 10–20 days, cycled 2–3 times per year.
Reported side effects
Reported as well-tolerated.